1. Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review article

   • Reham Alghandour
   • Doaa H. Sakr
   • Yasmin Shaaban

   Review Article Open access 02 May 2023 Pages: 1287 - 1300

   

2. Ofatumumab regimens in chronic lymphocytic leukemia: a meta-analysis

   • Muhammad Hossein Ashoub
   • Amirreza Naseri
   • Masoud Mohammadi

   Review Article 03 May 2023 Pages: 1301 - 1306

   

3. Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement

   • Mohammad Sayyadi
   • Saeed Hassani
   • Akbar Dorgalaleh

   Review Article 19 April 2023 Pages: 1307 - 1322

   

4. Heme oxygenase 1 in erythropoiesis: an important regulator beyond catalyzing heme catabolism

   • Rui Liu
   • Xuzhi Zhang
   • Huiyong Chen

   Review Article 12 April 2023 Pages: 1323 - 1332

   

5. A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia

   • Siddhibhong Jongkraijakra
   • Thitima Doungngern
   • Arnuparp Lekhakula

   Original Article 03 April 2023 Pages: 1333 - 1340

   

6. An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial

   • Maria Tsilika
   • John Mitrou
   • Evangelos J. Giamarellos-Bourboulis

   Original Article Open access 06 April 2023 Pages: 1341 - 1349

   

7. Association between vitamin D status and eryptosis–results from the German National Cohort Study

   • Franz Ewendt
   • Marvin Schmitt
   • Gabriele I. Stangl

   Original Article Open access 01 May 2023 Pages: 1351 - 1361

   

8. Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 cases

   • Núria Pujol-Moix
   • Eduardo Muñiz-Díaz
   • Juan Carlos Souto

   Original Article 31 March 2023 Pages: 1363 - 1374

   

9. Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials

   • Luigia Luciano
   • Roberto Latagliata
   • Massimo Breccia

   Original Article Open access 20 April 2023 Pages: 1375 - 1382

   

10. Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission – a multi-center study

    • Christophe Desprez
    • Achille Kouatchet
    • Corentin Orvain

    Original Article 11 April 2023 Pages: 1383 - 1393

    

11. Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects

    • Inge G.P. Geelen
    • Stein-Erik Gullaksen
    • Jeroen J.W.M. Janssen

    Original Article 29 April 2023 Pages: 1395 - 1408

    

12. Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort

    • Daniele Cattaneo
    • Cristina Bucelli
    • Alessandra Iurlo

    Original Article 20 April 2023 Pages: 1409 - 1420

    

13. Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma

    • Takashi Ishio
    • Shihori Tsukamoto
    • Takeshi Kondo

    Original Article Open access 12 April 2023 Pages: 1421 - 1431

    

14. The prognostic value of controlling nutritional status (CONUT) score–based nomogram on extranodal natural killer/T cell lymphoma patients

    • Shuo Zhang
    • Cai Sun
    • Wei Sang

    Original Article 19 April 2023 Pages: 1433 - 1442

    

15. Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis

    • Kimberley Doucette
    • Allison O. Taylor
    • Catherine Lai

    Original Article 24 April 2023 Pages: 1443 - 1458

    

16. The presence of two light chain bands on immunofixation is associated with poor outcomes in newly diagnosed multiple myeloma patients

    • Ameni Jerbi
    • Omar Turki
    • Hatem Masmoudi

    Original Article 15 April 2023 Pages: 1459 - 1466

    

17. Clinical outcomes after incomplete cycles of R-CHOP for diffuse large B-cell lymphoma: 10 years’ real-world experience in a single institute

    • Jeesun Yoon
    • Ki Hwan Kim
    • Jin Hyun Park

    Original Article 26 April 2023 Pages: 1467 - 1476

    

18. Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment

    • Taku Kikuchi
    • Nobuhiro Tsukada
    • Tadao Ishida

    Original Article 28 April 2023 Pages: 1477 - 1483

    

19. Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma

    • Yu Yagi
    • Yusuke Kanemasa
    • Tatsu Shimoyama

    Original Article 28 April 2023 Pages: 1485 - 1500

    

20. Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis

    • Martin Stork
    • Ivan Spicka
    • Ludek Pour

    Original Article Open access 24 April 2023 Pages: 1501 - 1511

    

21. Risk–benefit ratio of percutaneous kyphoplasty and percutaneous vertebroplasty in patients with newly diagnosed multiple myeloma with vertebral fracture: a single-center retrospective study

    • Qiu-Qing Xiang
    • Bin Chu
    • Li Bao

    Original Article Open access 30 March 2023 Pages: 1513 - 1522

    

22. Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells

    • Xia Xiong
    • Yibing Yu
    • Mingfeng Zhao

    Original Article 22 April 2023 Pages: 1523 - 1535

    

23. Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

    • Muzaffer Keklik
    • Burak Deveci
    • Olcay Y. Jones

    Original Article 17 April 2023 Pages: 1537 - 1547

    

24. Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics

    • Satoshi Yamasaki
    • Shohei Mizuno
    • Masamitsu Yanada

    Original Article 01 May 2023 Pages: 1549 - 1559

    

25. Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide

    • Ignacio Gómez-Centurión
    • Reyes Maria Martin Rojas
    • Mi Kwon

    Original Article 21 April 2023 Pages: 1561 - 1567

    

26. Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme

    • Lu Wang
    • Peiyan Kong
    • Xi Zhang

    Original Article Open access 25 April 2023 Pages: 1569 - 1579

    

27. Brazilian experience with caplacizumab in acquired thrombotic thrombocytopenic purpura: outcomes of the expanded access program

    • Tiago de Oliveira Boechat
    • João Samuel de Holanda Farias
    • Michaela Larissa Lobo de Andrade

    Original Article 13 April 2023 Pages: 1581 - 1588

    

28. Gut microbiome alterations in patients with COVID-19-related coagulopathy

    • Youli Chen
    • Xin Li
    • Xiaohua Hou

    Original Article 11 April 2023 Pages: 1589 - 1598

    

29. Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient

    • Süreyya Yiğit Kaya
    • Sebnem Bektas
    • Ömür Gökmen Sevindik

    Letter to the Editor 26 April 2023 Pages: 1599 - 1600

30. T-cell lymphoma associated with dupilumab

    • Mitsuhiro Shimada
    • Shojiro Inano
    • Toshiyuki Kitano

    Letter to the Editor 27 April 2023 Pages: 1601 - 1602

    

31. Meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data

    • Andrea Messori
    • Giulia Hyeraci

    Letter to the Editor 06 March 2023 Pages: 1603 - 1605

32. Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic

    • Luca Guarnera
    • Elisa Buzzatti
    • Maria Ilaria Del Principe

    Letter to the Editor 25 March 2023 Pages: 1607 - 1608

    

33. Staphylococcus intermedius infection with splenic abscesses in a patient with acute lymphoblastic leukemia

    • Lisa Hauptmann
    • Danica Midic
    • Ulf Schnetzke

    Letter to the Editor Open access 04 April 2023 Pages: 1609 - 1611

    

34. Aleukemic mast cell leukemia, well-differentiated and chronic type

    • Kenneth Chen
    • Paul C. Hendrie
    • Kikkeri N. Naresh

    Letter to the Editor 04 April 2023 Pages: 1613 - 1615

    

35. Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma

    • Enrico Schalk
    • Kathleen Jentsch-Ullrich

    Letter to the Editor Open access 16 March 2023 Pages: 1617 - 1620

36. Hematopoietic cell transplantation for congenital dyserythropoietic anemia IV caused by compound heterozygous KLF1 mutations

    • Kun Yang
    • Weiye Nie
    • Xiaolin Yin

    Letter to the Editor 31 March 2023 Pages: 1621 - 1624

    

37. Solitary follicular lymphoma with plasmacytic differentiation associated with localized AL amyloidosis in the jejunum

    • Katsushi Tajima
    • Takashi Nomura
    • Hironobu Naiki

    Letter to the Editor 05 April 2023 Pages: 1625 - 1627